Skip to main content
. 2012 Apr 13;7(4):e35012. doi: 10.1371/journal.pone.0035012

Figure 2. Treatment-induced RNA and gene expression changes.

Figure 2

(A) Total number of RNA state changes (up- or downregulation) in human hepatocytes treated with aleglitazar, tesaglitazar or Pio/Feno. (B) Unique and shared gene expression following treatment with aleglitazar, tesaglitazar or Pio/Feno.